Investigating the cost implications of including all respiratory medicines in PCRS schemes

ConclusionsRespiratory disease is included in the Irish Government ’s chronic disease management programme. This aims to deliver optimal care in the most appropriate setting so as to improve health outcomes and quality of life. Medication adherence is imperative to achieving these aims. Reducing cost barriers as a complement to other initiatives may improve medic ine adherence thereby improving the effectiveness of disease management and patient outcomes.
Source: Irish Journal of Medical Science - Category: General Medicine Source Type: research